Literature DB >> 15061600

Alternative cancer cures: "unproven" or "disproven"?

Andrew Vickers1.   

Abstract

Oncology has always coexisted with therapies offered outside of conventional cancer treatment centers and based on theories not found in biomedicine. These alternative cancer cures have often been described as "unproven," suggesting that appropriate clinical trials have not been conducted and that the therapeutic value of the treatment is unknown. Contrary to much popular and scientific writing, many alternative cancer treatments have been investigated in good quality clinical trials, and they have been shown to be ineffective. In this article, clinical trial data on a number of alternative cancer cures including Livingston-Wheeler, Di Bella Multitherapy, antineoplastons, vitamin C, hydrazine sulfate, Laetrile, and psychotherapy are reviewed. The label "unproven" is inappropriate for such therapies; it is time to assert that many alternative cancer therapies have been "disproven."

Entities:  

Mesh:

Year:  2004        PMID: 15061600     DOI: 10.3322/canjclin.54.2.110

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  3 in total

1.  Rapid quantitative typing spectra model for distinguishing sweet and bitter apricot kernels.

Authors:  Xue Huang; Jiayi Xu; Feng Gao; Hongyan Zhang; Ling Guo
Journal:  Food Sci Biotechnol       Date:  2022-06-23       Impact factor: 3.231

2.  Depression and the use of complementary medicine among breast cancer patients.

Authors:  Ali Montazeri; Akram Sajadian; Mandana Ebrahimi; Mohammad Esmail Akbari
Journal:  Support Care Cancer       Date:  2004-11-12       Impact factor: 3.603

Review 3.  Effects of the Gut microbiota on Amygdalin and its use as an anti-cancer therapy: Substantial review on the key components involved in altering dose efficacy and toxicity.

Authors:  Vani Jaswal; Jeyanthi Palanivelu; Ramalingam C
Journal:  Biochem Biophys Rep       Date:  2018-05-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.